Thomas Chan

2.5k total citations
68 papers, 1.8k citations indexed

About

Thomas Chan is a scholar working on Molecular Biology, Oncology and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Thomas Chan has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Oncology and 8 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Thomas Chan's work include Biochemical and Molecular Research (7 papers), Cancer therapeutics and mechanisms (7 papers) and CO2 Reduction Techniques and Catalysts (6 papers). Thomas Chan is often cited by papers focused on Biochemical and Molecular Research (7 papers), Cancer therapeutics and mechanisms (7 papers) and CO2 Reduction Techniques and Catalysts (6 papers). Thomas Chan collaborates with scholars based in United States, Canada and Australia. Thomas Chan's co-authors include Morley C. Sutter, Deborah W. Knapp, Stephen B. Howell, Ralph C. Richardson, Robert Teclaw, G. D. Bottoms, Thomas Kuczek, Dennis B. DeNicola, Mark A. Ashwell and Erika Volckova and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Chemical Physics.

In The Last Decade

Thomas Chan

65 papers receiving 1.8k citations

Peers

Countries citing papers authored by Thomas Chan

Since Specialization

Citations

This map shows the geographic impact of Thomas Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Chan more than expected).

Fields of papers citing papers by Thomas Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Chan. The network helps show where Thomas Chan may publish in the future.

Co-authorship network of co-authors of Thomas Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Chan. A scholar is included among the top collaborators of Thomas Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Chan. Thomas Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cambered Bipyridyl Ligand with Extended Aryl System Enables Electrochemical Reduction of Carbon Dioxide and Bicarbonate by Mn(bpy)(CO)₃Br-type Catalyst Immobilized on Carbon Nanotubes 2025 ·Journal of the American Chemical Society ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cheol Woo Park, Colin K. Loeb, Thomas Chan, Clifford P. Kubiak	5
2	Realization of a Photoelectrochemical Cascade for the Generation of Methanol: A Liquid Solar Fuel 2024 ·Energy & Fuels ·Thomas Chan, (unknown), (unknown), (unknown), Alex J. King, Rajiv Ramanujam Prabhakar, (unknown), Michelle Young, (unknown), Myles A. Steiner, Adele C. Tamboli, Emily L. Warren, Clifford P. Kubiak, Joel W. Ager, Ann L. Greenaway	0
3	Steric Effects on CO₂ Reduction with Substituted Mn(bpy)(CO)₃X-Type Catalysts on Multiwalled Carbon Nanotubes Reveal Critical Mechanistic Details 2024 ·ACS Catalysis ·(unknown), Thomas Chan, (unknown), Byunghoon Lee, Rajiv Ramanujam Prabhakar, Clifford P. Kubiak	10
4	Simple Preparation and Characterization of Hybrid Cobalt Phthalocyanine on Multiwalled Carbon Nanotube Electrodes 2024 ·ACS Applied Energy Materials ·Thomas Chan, (unknown), (unknown), Colin K. Loeb, (unknown), Amy A. Cordones, Clifford P. Kubiak	6
5	Layer-by-Layer Deposition of Rh(I) Diisocyanide Coordination Polymers on Au(111) and Their Chemical and Electrochemical Stability 2022 ·The Journal of Physical Chemistry C ·(unknown), Thomas Chan, (unknown), Clifford P. Kubiak	7
6	PM-IRRAS and DFT investigation of the surface orientation of new Ir piano-stool complexes attached to Au(111) 2022 ·Dalton Transactions ·Christopher J. Miller, (unknown), H. Ray Kelly, Po Ling Cheung, Nicole A. Torquato, Milan Gembický, (unknown), Thomas Chan, Víctor S. Batista, Clifford P. Kubiak	3
7	Synthesis, structure and reactivity of μ₃-SnH capped trinuclear nickel cluster 2022 ·Chemical Science ·Nicole A. Torquato, (unknown), (unknown), (unknown), Thomas Chan, Milan Gembický, Anthony A. Mrse, Clifford P. Kubiak	2
8	A particle finite element-based model for droplet spreading analysis 2020 ·Physics of Fluids ·(unknown), (unknown), Thomas Chan, Pavel Ryzhakov, Adam Z. Weber, R. V. Roy, Marc Secanell	9
9	Abstract #820: Combination studies of tyrosine kinase inhibitors (TKIs): Assessment of potential cytotoxic synergy of ARQ 197 with sorafenib or sunitinib 2009 ·Cancer Research ·Chang-Rung Chen, (unknown), Atipat Rojnuckarin, (unknown), Li Huang, (unknown), Susan Cornell-Kennon, (unknown), (unknown), Charles W. Bruseo, Thomas Chan	6
10	Identification of the in Vitro Metabolites of 3,4-Dihydro-2,2-dimethyl-2H-naphthol[1,2-b ]pyran-5,6-dione (ARQ 501; β-Lapachone) in Whole Blood 2008 ·Drug Metabolism and Disposition ·Xiu‐Sheng Miao, (unknown), Ronald E. Savage, Caiyun Zhong, Rui‐Yang Yang, Darin Kizer, Hui Wu, Erika Volckova, Mark A. Ashwell, Jeffrey G. Supko, Xiaoying He, Thomas Chan	25
11	In vitro metabolism of β ‐lapachone (ARQ 501) in mammalian hepatocytes and cultured human cells 2008 ·Rapid Communications in Mass Spectrometry ·Xiu‐Sheng Miao, Caiyun Zhong, Yunxia Wang, Ronald E. Savage, Rui‐Yang Yang, Darin Kizer, Erika Volckova, Mark A. Ashwell, Thomas Chan	19
12	Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of ARQ 501 (β-lapachone) in plasma and tumors from nu/nu mouse xenografts 2008 ·Journal of Chromatography B ·Ronald E. Savage, T. W. HALL, (unknown), (unknown), (unknown), Thomas Chan	13
13	ARQ 197, a small molecule inhibitor of c-met, prevents bone metastasis in a humanized mouse model of breast cancer 2007 ·Molecular Cancer Therapeutics ·K. C. Anderson, Chiang Li, Jodie E. Moreau, Thomas Chan, Michael Rosenblatt	7
14	Enhanced Econazole Penetration into Human Nail by 2-n-Nonyl-1,3-dioxolane 2002 ·Journal of Pharmaceutical Sciences ·Xiaoying Hui, Thomas Chan, (unknown), Christine Lee, Howard I. Maibach, Ronald C. Wester	52
15	Polymers Effect on Estradiol Partition Coefficient between Powdered Human Stratum Corneum and Water 2002 ·Journal of Pharmaceutical Sciences ·Ronald C. Wester, Xiaoying Hui, Philip Hewitt, Jurij J. Hostýnek, (unknown), Thomas Chan, Howard I. Maïbach	6
16	Recombinant Human Osteogenic Protein‐1 (OP‐1) Stimulates Periodontal Wound Healing in Class III Furcation Defects 1998 ·Journal of Periodontology ·William V. Giannobile, (unknown), Mei‐Shu Shih, (unknown), Paul L. Kaplan, Thomas Chan	176
17	Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke 1998 ·Neuroreport ·Takakazu Kawamata, JingMei Ren, Thomas Chan, Marc Charette, Seth P. Finklestein	73
18	Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells 1995 ·American Journal of Veterinary Research ·Deborah W. Knapp, Thomas Chan, Thomas Kuczek, William J. Reagan, (unknown)	56
19	Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder 1994 ·Journal of Veterinary Internal Medicine ·Deborah W. Knapp, Ralph C. Richardson, Thomas Chan, G. D. Bottoms, William R. Widmer, Dennis B. DeNicola, Robert Teclaw, Patty L. Bonney, Thomas Kuczek	226
20	Mechanism-based model for tumor drug resistance 1992 ·Cancer Chemotherapy and Pharmacology ·Thomas Kuczek, Thomas Chan	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact